Who Owns CDTX?

CIDARA THERAPEUTICS INC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

46

Total Inst. Value

$194.0M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1RA CAPITAL MANAGEMENT, L.P.$23.5M1,092,796
2VR Adviser, LLC$22.6M1,051,518
3TCG Crossover Management, LLC$21.7M1,005,901
4ADAGE CAPITAL PARTNERS GP, L.L.C.$21.3M990,000
5BVF INC/IL$19.9M924,642
6Bain Capital Life Sciences Investors, LLC$15.1M703,080
7Vivo Capital, LLC$14.7M684,276
8Vestal Point Capital, LP$10.9M504,542
9SUSQUEHANNA INTERNATIONAL GROUP, LLP$7.4M342,476
10CITADEL ADVISORS LLC$6.2M287,775

Famous Fund Managers

Frequently Asked Questions

How many institutional investors hold CDTX?

As of Q1 2025, 46 institutional investors report holding CDTX (CIDARA THERAPEUTICS INC) in their 13F filings.

Which hedge fund owns the most CDTX?

The largest institutional holder of CDTX is RA CAPITAL MANAGEMENT, L.P. with $23.5M in shares.

Are institutions buying or selling CDTX?

This quarter, 46 institutions opened new positions in CDTX and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.